Abstract

Introduction: Smoking is a well known risk factor for coronary artery disease (CAD). Moreover, controversial data suggest that the -174 G/C polymorphism on Interleukin-6 (IL-6) gene promoter (rs1800795) may represent an early marker of inflammatory activation, closely related to the initiation and evolution of atherosclerosis. However, no data exist concerning a combined effect of smoking and this IL-6 genetic variant on several aspects of inflammation and thrombosis, endothelial function and the presence of CAD. Methods: 646 subjects (361 non smokers) were subjected to appropriate genotyping. Endothelial function was assessed by the flow mediated dilatation (FMD) of brachial artery. IL-6 (pg/ml), Tumor Necrosis Factor-a (TNF-a) (pg/ml), high sensitivity CRP (hsCRP) (mg/l) and D-dimers (μg/l) were measured with appropriate methods. Results: An increased incidence of CAD was found among the carriers of the allele C, compared to GG homozygotes, (OR:1.59, CI:1.26-2.93, p=0.032) in smokers, while a decreased incidence was observed in non smokers (OR:0.42, CI:0.26-0.68, p<0.001), after adjustment for all risk factors for CAD. The C allele carriers, compared to GG homozygotes, were associated with significantly higher serum levels of IL-6 (3.09±1.4 vs 1.3±0.7), TNF-a (5.3±2.4 vs 2.57±1.8), hsCRP (2.09±0.9 vs 1.05±0.69) in smokers as well as in non smokers (IL-6: 2.62±1.2 vs 1.64±0.89, TNF-a: 3.57±1.67 vs 4.43±2.1, hsCRP: 1.84±0.82 vs 1.62±0.77), p<0.01 for all. Importantly, the C allele, compared to GG homozygotes, enhanced the expression of fibrinogen (488.3±115.1 vs 318.5±61.1 p<0.001) and D-dimers (513±313.4 vs 355.1±218.4, p=0.025) in smokers, while it down-regulated the expression of fibrinogen in non-smokers (351.9±84.5 vs 479.4±126.4, p<0.001). Impressively, the C allele carriers were correlated with significantly impaired endothelial function in the smoking group (3.9±2.7 vs 5.2±3.3, p=0.003), while no effect was observed among non-smokers (4.8±2.9 vs 5.04±2.6, p=0.64). Conclusions: The C allele of rs1800795 exerts a synergistic effect on smoking resulting to a significantly increased risk for CAD. This action is mediated by inflammatory and thrombotic mechanisms as well as by the impairment of endothelial function.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.